Literature DB >> 1576180

Lifetime diagnoses in patients with somatoform disorders: which came first?

W Rief1, S Schaefer, W Hiller, M M Fichter.   

Abstract

Thirty inpatients with somatoform disorders were examined with the structured clinical interview SCID for psychiatric lifetime diagnosis. In the present diagnoses, we found a concordance of 63% for somatoform and affective disorders and the lifetime comorbidity of both disorders was 87%. Additionally, patients with somatoform disorders frequently had a history of other psychiatric disorders (for example, anxiety disorders, 40%). For 73% of patients with somatoform disorders and a history of affective disorders, the onset of the somatoform disorder was prior to the onset of another psychiatric disorder. The time interval between the onsets of somatoform disorders and affective disorders was greater than 1 year for most patients; for 46% of the patients with a history of both disorders, the time interval between the two disorders was more than 5 years. The course of illness for somatoform and affective disorders was quite different; while affective disorders tended to episodic periods with interim remissions, the somatoform disorders usually showed long, chronic courses (mean duration of the current somatoform disorder was 11.9 years). Finally, the Symptom Check List SCL-90R demonstrated good discrimination between patients with affective and anxiety disorders. However, the SCL-90R failed to discriminate patients with somatoform disorders from affective- and anxiety-disordered subjects. Therefore, the development of other psychometric scales is necessary for the evaluation of patients with somatoform disorders.

Entities:  

Mesh:

Year:  1992        PMID: 1576180     DOI: 10.1007/bf02190259

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  20 in total

1.  Somatization: medicine's unsolved problem.

Authors:  Z J Lipowski
Journal:  Psychosomatics       Date:  1987-06       Impact factor: 2.386

2.  Excess medical care of women with somatization disorder.

Authors:  M S Zoccolillo; C R Cloninger
Journal:  South Med J       Date:  1986-05       Impact factor: 0.954

3.  Why do some psychiatric patients somatize?

Authors:  J de León; J Saiz-Ruiz; A Chinchilla; P Morales
Journal:  Acta Psychiatr Scand       Date:  1987-08       Impact factor: 6.392

4.  The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory.

Authors:  L R Derogatis; R S Lipman; K Rickels; E H Uhlenhuth; L Covi
Journal:  Behav Sci       Date:  1974-01

5.  Mood and somatic symptoms.

Authors:  L O Persson; L Sjöberg
Journal:  J Psychosom Res       Date:  1987       Impact factor: 3.006

Review 6.  Somatization and depression.

Authors:  Z J Lipowski
Journal:  Psychosomatics       Date:  1990       Impact factor: 2.386

7.  Masked depression in a combined medical-psychiatric unit.

Authors:  A Stoudemire; M Kahn; J T Brown; E Linfors; J L Houpt
Journal:  Psychosomatics       Date:  1985-03       Impact factor: 2.386

8.  Characterizing life events as risk factors for depression: the role of fateful loss events.

Authors:  P E Shrout; B G Link; B P Dohrenwend; A E Skodol; A Stueve; J Mirotznik
Journal:  J Abnorm Psychol       Date:  1989-11

9.  Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilization.

Authors:  G R Smith; R A Monson; D C Ray
Journal:  Arch Intern Med       Date:  1986-01

10.  Life events and somatisation among students.

Authors:  D Scaloubaca; P Slade; F Creed
Journal:  J Psychosom Res       Date:  1988       Impact factor: 3.006

View more
  2 in total

1.  The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severity.

Authors:  Dirk Wedekind; Borwin Bandelow; Evelyn Fentzahn; Patricia Trümper; Eckart Rüther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-01-02       Impact factor: 5.270

2.  Somatoform symptoms in depressive and panic syndromes.

Authors:  W Rief; W Hiller; M M Fichter
Journal:  Int J Behav Med       Date:  1995
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.